Nestl Health Science SA, a fully-owned subsidiary of Nestl SA, and Hutchison China MediTech have announced that all regulatory approvals required for the establishment of a 50/50 joint venture Nutrition Science Partners Limited have been received.
Hutchison China MediTech said that the purpose of the joint venture would be to research, develop, manufacture and market novel medicines and nutritional products derived from botanical plant origins.
The company added that Nutrition Science Partners would focus on gastrointestinal indications and could in the future expand into the metabolic disease and brain health areas.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Hutchison China MediTech's share price was up 3.85% to 526.50p at 11:13 on Friday.
MF
-
House price affordability improves, but average first-time buyer still paying five times salaryNationwide has reported a “modest improvement” in house price affordability over the past year, with wages outstripping house price growth, but challenges remain.
-
How to profit from the scramble for metals and mineralsCopper and other metals will be vital in the transition to cleaner technologies and artificial intelligence. Soaring demand is pushing prices up
